Whether a cancer treatment is CAR-T cells, checkpoint inhibitors, or adoptive T cell therapy, the mechanism of action includes T cell lysis of tumor cells.

Watch this webinar to see data using Cellero’s tumor antigen-specific T cells and commonly available tumor cell lines to demonstrate specific lysis of tumor cells using the Incucyte® Live-Cell Analysis.

Fill out the form to access the full webinar recording and additional resources.